At the annual general meeting of shareholders of Novartis in February 2008, the shareholders authorized the Board to launch the current share buy-back program to repurchase Novartis shares up to a maximum amount of CHF 10 billion via a second trading line on the SIX.
Official notices in German and French
Repurchases of Novartis shares are carried out on a second trading line on the SIX Swiss Exchange, with Novartis as the exclusive buyer.
A shareholder wishing to sell Novartis shares may do so either via the ordinary trading line or via the second line. Novartis shares sold via the second trading line are subject to the Swiss federal withholding tax rate of 35 percent on the difference between the repurchase price of the Novartis share and its nominal value of CHF 0.50. This withholding tax can be reclaimed by qualified investors.